BiPAP vs CPAP in Pediatric Patients
Consider BiPAP (non-invasive ventilation/NIV) over CPAP for mild-to-moderate cardiorespiratory failure in children, as BiPAP provides ventilatory support with two pressure levels that can better assist with CO2 removal and reduce work of breathing, while CPAP should be reserved for simpler oxygenation support in mixed disease or as initial therapy when ventilatory assistance is not required. 1
Decision Framework Based on Disease Severity and Type
When to Use CPAP
- CPAP may be considered as initial support in mixed disease (restrictive and obstructive components) with mild-to-moderate severity 1
- CPAP is appropriate for mild-to-moderate cardiorespiratory failure when the primary issue is maintaining end-expiratory lung volume and oxygenation 1
- CPAP provides a single continuous pressure level (typically 5-8 cmH2O) that maintains airway patency and functional residual capacity 1
- In upper airway obstruction (laryngomalacia, tracheomalacia), CPAP significantly reduces respiratory effort without the patient-ventilator asynchrony seen with BiPAP 2
When to Use BiPAP (NIV)
- BiPAP should be considered before intubation in obstructive airway disease, restrictive disease, mild-to-moderate PARDS, or cardiorespiratory failure 1
- BiPAP is superior for CO2 removal and reducing work of breathing compared to CPAP, particularly when ventilatory support (not just oxygenation) is needed 3
- In neonates and preterm infants with respiratory distress syndrome, BiPAP reduces intubation rates within 72 hours compared to CPAP 4
- BiPAP shortens duration of positive airway pressure support and oxygen supplementation compared to CPAP 5
Physiologic Rationale
The key distinction lies in the mechanism of support:
- CPAP delivers one constant pressure throughout the respiratory cycle, primarily improving oxygenation by maintaining alveolar recruitment and functional residual capacity 1
- BiPAP delivers two pressure levels (higher inspiratory pressure, lower expiratory pressure), providing active ventilatory assistance that augments tidal volume and enhances CO2 clearance 1, 3
- BiPAP's higher inspiratory pressure reduces work of breathing more effectively than CPAP in patients with increased respiratory effort 2
Critical Caveats and Monitoring
Do Not Delay Intubation
- Neither CPAP nor BiPAP should delay endotracheal intubation when clinically indicated 1
- Assess success of non-invasive support within 1 hour by monitoring heart rate, respiratory rate, SpO2/FiO2 ratio, pH, level of consciousness, and presence of organ failure 1
Avoid BiPAP in Severe Disease
- BiPAP is not recommended for severe cardiorespiratory failure where intubation is likely needed 1
- In adult studies, NIV increased adverse outcomes in severe ARDS, suggesting caution in severe pediatric disease 1
Interface Selection
- There is insufficient data to recommend a specific optimal interface (nasal mask, full face mask, helmet) for either CPAP or BiPAP 1
- Use the interface with the least air leakage based on local experience and available materials 1
Patient-Ventilator Asynchrony
- BiPAP may cause patient-ventilator asynchrony, particularly in infants with upper airway obstruction, where CPAP may be preferable 2
Special Populations
Neuromuscular Patients
- Consider non-invasive ventilation (BiPAP) in neuromuscular patients for weaning and post-extubation support 1
- Consider cough-assist devices in neuromuscular patients 1
Cardiac Patients
- The same principles for CPAP vs BiPAP apply to cardiac children as non-cardiac children 1
- Sufficient PEEP should be used to maintain end-expiratory lung volume regardless of pulmonary blood flow status 1
Neonates and Preterm Infants
- BiPAP reduces reintubation rates and bronchopulmonary dysplasia compared to CPAP in preterm infants with respiratory distress syndrome 6, 5
- BiPAP demonstrates faster improvement in blood gas parameters (reduced PaCO2, increased pH and PaO2) within 1 hour compared to CPAP in term neonates 3